Success Stories: Thanks to Premium Processing, an Indian Research Scientist in Molecular Biology Gets EB1-A Approval in Just 13 Days

Client’s Testimonial:

“Thank you very much, I am happy with your service.”

On August 30^th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: August 30^th, 2021

Processing Time: 13 days (Premium Processing Requested)

Case Summary:

The clear national importance of one of our client’s research has led him to find funding from 2 leading national institutes, namely the American Heart Association and the National Institutes of Health. While these grants are reserved solely for research directed at advancing the national interest, they go beyond that and have an impact globally. This is what we showcased as the forerunner while building a strong EB1-A (Alien of Extraordinary Ability) case based on his history as a Ph.D. scholar in Pharmacology wanting to pursue a career in molecular biology. This is also what some of the experts in the field had to say of his work:

“[Client’s] research in the field of molecular biology contributes to the development of targeted treatment strategies for sepsis, among other conditions, and thus directly contributes to the improved treatment and survivability of one of the world’s most pressing medical emergencies.”

“In his research in the field of molecular biology, [client] investigates the implementation of nanotechnology in the development of novel drug and gene delivery methods and characterizes the role of different molecular mechanisms in inflammation and tumorigenesis. His novel methods directly contribute to the development of advanced cancer treatment strategies, which have implications for the improved survivability of various cancers in the United States.”

At the same time, in his research in the field of molecular biology, he conducts critical studies into the role of a variety of molecular mechanisms in inflammation and sepsis. His research directly enables the development of advanced therapeutic treatments and drug delivery methods, and his continued research is, therefore, crucial to improved public health outcomes around the world.

Detailing his other academic records, we pointed out how he has completed at least 30 reviews to date. His research has also resulted in 16 peer-reviewed journal articles (3 of them first-authored), 3 peer-reviewed conference papers, and 1 book chapter, and these publications have been cited a total of 678 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of molecular biology. Given that only the most highly esteemed researchers in the field are invited to evaluate the work of their peers, it is clear that he is seen as very knowledgeable in the field.

All of this put together helped make a very convincing case in front of the adjudicating authorities pushing them to take a favorable decision for our client, who then decided to retain us for filing his NIW and I-485 petitions as well. We are thankful to him for his continued trust in NAILG.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.